PortfoliosLab logoPortfoliosLab logo
FPHAX vs. IHE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

FPHAX vs. IHE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Select Pharmaceuticals Portfolio (FPHAX) and iShares U.S. Pharmaceuticals ETF (IHE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FPHAX achieves a 14.61% return, which is significantly lower than IHE's 18.61% return. Over the past 10 years, FPHAX has outperformed IHE with an annualized return of 12.03%, while IHE has yielded a comparatively lower 8.74% annualized return.


FPHAX

1D
-2.10%
1M
2.49%
6M
12.61%
YTD
14.61%
1Y
44.31%
3Y*
21.13%
5Y*
13.21%
10Y*
12.03%

IHE

1D
-0.52%
1M
5.85%
6M
17.45%
YTD
18.61%
1Y
51.48%
3Y*
21.44%
5Y*
11.79%
10Y*
8.74%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FPHAX vs. IHE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FPHAX
Fidelity Select Pharmaceuticals Portfolio
14.61%30.41%9.39%12.54%0.94%11.79%11.16%31.73%5.41%10.70%
IHE
iShares U.S. Pharmaceuticals ETF
18.61%31.69%8.13%1.06%-4.87%13.07%13.66%15.47%-7.76%10.64%

Correlation

The correlation between FPHAX and IHE is 0.91, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.91

Correlation (3Y)
Calculated over the trailing 3-year period

0.85

Correlation (5Y)
Calculated over the trailing 5-year period

0.85

Correlation (10Y)
Calculated over the trailing 10-year period

0.86

Correlation (All Time)
Calculated using the full available price history since May 5, 2006

0.89

The correlation between FPHAX and IHE has been stable across timeframes, ranging from 0.85 to 0.91 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FPHAX vs. IHE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FPHAX
FPHAX Risk / Return Rank: 8080
Overall Rank
FPHAX Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
FPHAX Sortino Ratio Rank: 7878
Sortino Ratio Rank
FPHAX Omega Ratio Rank: 6969
Omega Ratio Rank
FPHAX Calmar Ratio Rank: 9393
Calmar Ratio Rank
FPHAX Martin Ratio Rank: 8080
Martin Ratio Rank

IHE
IHE Risk / Return Rank: 9494
Overall Rank
IHE Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
IHE Sortino Ratio Rank: 9595
Sortino Ratio Rank
IHE Omega Ratio Rank: 9191
Omega Ratio Rank
IHE Calmar Ratio Rank: 9595
Calmar Ratio Rank
IHE Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FPHAX vs. IHE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Pharmaceuticals Portfolio (FPHAX) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FPHAXIHEDifference
Sharpe ratioReturn per unit of total volatility

-0.81

Sortino ratioReturn per unit of downside risk

-1.27

Omega ratioGain probability vs. loss probability

1.34

1.48

-0.14

Calmar ratioReturn relative to maximum drawdown

4.14

6.11

-1.97

Martin ratioReturn relative to average drawdown

11.30

18.66

-7.36

FPHAX vs. IHE - Sharpe Ratio Comparison

The current FPHAX Sharpe Ratio is 2.05, which is comparable to the IHE Sharpe Ratio of 2.87. The chart below compares the historical Sharpe Ratios of FPHAX and IHE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FPHAX vs. IHE - Drawdown Comparison

The maximum FPHAX drawdown since its inception was -38.26%, roughly equal to the maximum IHE drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for FPHAX and IHE.


Loading charts...

Drawdown Indicators


FPHAXIHEDifference

Max Drawdown

Largest peak-to-trough decline

-38.26%

-38.20%

-0.06%

Max Drawdown (1Y)

Largest decline over 1 year

-10.33%

-8.47%

-1.86%

Max Drawdown (3Y)

Largest decline over 3 years

-28.82%

-15.92%

-12.90%

Max Drawdown (5Y)

Largest decline over 5 years

-28.82%

-16.03%

-12.79%

Max Drawdown (10Y)

Largest decline over 10 years

-28.82%

-29.59%

+0.77%

Current Drawdown

Current decline from peak

-3.71%

-3.32%

-0.39%

Average Drawdown

Average peak-to-trough decline

-9.14%

-7.88%

-1.26%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.78%

2.77%

+1.01%

Volatility

FPHAX vs. IHE - Volatility Comparison

Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a higher volatility of 7.19% compared to iShares U.S. Pharmaceuticals ETF (IHE) at 6.74%. This indicates that FPHAX's price experiences larger fluctuations and is considered to be riskier than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FPHAXIHEDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.19%

6.74%

+0.45%

Volatility (6M)

Calculated over the trailing 6-month period

15.17%

13.69%

+1.48%

Volatility (1Y)

Calculated over the trailing 1-year period

20.84%

18.09%

+2.75%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.28%

16.48%

+1.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

17.90%

18.06%

-0.16%

FPHAX vs. IHE - Expense Ratio Comparison

FPHAX has a 0.75% expense ratio, which is higher than IHE's 0.38% expense ratio.


Dividends

FPHAX vs. IHE - Dividend Comparison

FPHAX's dividend yield for the trailing twelve months is around 4.85%, more than IHE's 1.47% yield.


PositionTTM20252024202320222021202020192018201720162015
FPHAX
Fidelity Select Pharmaceuticals Portfolio
4.85%5.68%1.90%8.08%5.18%11.09%8.85%8.33%1.65%1.62%1.07%12.63%
IHE
iShares U.S. Pharmaceuticals ETF
1.47%1.76%1.73%1.39%2.01%1.49%1.19%1.40%1.25%1.36%0.92%1.93%

Frequently Asked Questions


With a correlation of 0.91, FPHAX and IHE move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.

FPHAX has higher volatility (7.19%) compared to IHE (6.74%). In terms of maximum drawdown, FPHAX dropped -38.26% vs IHE's -38.20%.

IHE currently has the higher Sharpe Ratio (2.87 vs 2.05), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FPHAX and IHE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer